Kombucha's health claims typically invoke organic acids and polyphenols โ compounds already present in tea, modified by fermentation. Kim, Baek, and colleagues at Fermentation (2025) showed the microbial community can do something more specific: synthesize gamma-aminobutyric acid, a neurotransmitter, from scratch.
They replaced the wild SCOBY with a designed three-strain starter: Acetobacter pasteurianus for acetic acid production, Saccharomyces cerevisiae for ethanol and COโ, and Lactiplantibacillus plantarum selected specifically for its glutamate decarboxylase enzyme, which converts glutamic acid to GABA. The GABA doesn't come from the tea. It's manufactured by the bacterium during fermentation.
The design space is in the inoculation ratio and sugar concentration. Tuning these parameters balances the three metabolic systems to produce a beverage with acetic acid, lactic acid, and GABA simultaneously โ three functional outputs from three engineered strains.
What's conceptually interesting is the shift from preservation to synthesis. Traditional fermentation preserves food by creating hostile environments for pathogens (acidity, alcohol). This designed fermentation creates a psychoactive compound. The microbial community isn't a defense system โ it's a chemical factory producing a molecule that acts on the consumer's nervous system.
The through-claim: when fermentation is understood as microbial synthesis rather than microbial preservation, the design space expands from "what can we keep from spoiling" to "what can we build from substrate." The microbes become the manufacturing process, not the preservation mechanism.